POST Online Media Lite Edition



 

NEWLY REPORTED COVID-19 CASES IN LAST 24 HOURS (4.20.2021, 10:36am CEST, WHO):   U.S. 38,084    India 259,170    Brazil 42,980    France 29,344    Russia 8,589    The United Kingdom 1,882    Turkey 55,802    Italy 12,688    Poland 7,302    Argentina 16,267    Columbia 16,871    Iran 24,346    Ukraine 6,506    Peru 7,131    Indonesia 4,952    Czechia 2,364    South Africa 1,089    The Netherlands 8,600    Chile 6,622    Canada 7,591    Romania 2,265    Iraq 7,775    Philippines 9,628    Pakistan 5,152    Hungary 2,680    Bangladesh 4,271    Jordan 3,509    Serbia 2,069    Austria 2,159    Japan 3,265    United Arab Emirates 1,803    Malaysia 2,078    Belarus 1,300    Greece 1,829    Azerbaijan 2,144    Tunisia 1,571    Nepal 1,227    Kuwait 1,510    Paraguay 1,801    Ethiopia 1,792    Venezuela 1,287    Oman 1,399    Bahrain 1,008    Uruguay 2,344    Puerto Rico 1,348    Cuba 1,060    Thailand 1,443    China 25    Singapore 20    New Zealand 1    Australia 24    South Korea 549   

Doctors in South Korea successfully detect cancer cells in blood

Staff Writer |
A group of South Korean doctors discovered a method to successfully detect cancer cells within a small blood sample, the state-run cancer institute said.

Article continues below






This is a discovery that could lead to a broad range of practical clinical applications in the diagnosis and treatment of cancer.

The team led by Cho Young-koo at the National Cancer Center successfully detected and isolated circulating tumor cells (CTC) in blood samples of early-stage breast cancer patients.

CTCs have been recognized as promising biomarkers for diagnosis and indication of several cancers. However, CTC monitoring at present is available only for advanced-stage patients rather than for those in an early stage.

The researchers developed a method using magnetic nanowires to aid in the efficient isolation and detection of CTCs in the blood of patients, especially those with early-stage cancers, the institute said.

"The detection of CTCs will greatly help not only the early diagnosis of cancer but also in treatment," said Cho, adding that the technology involves just simply drawing blood from patients not a biopsy.


What to read next

Low-cost blood test could be key weapon against No. 4 cancer killer in U.S.
Researchers find how cancer cells may become resistant to drugs
Leukaemia - The Introduction